Evidence map›Paper›PMID 21546085›Full record

ReviewPlacenta2011

Pregnancy-associated progenitor cells: an under-recognized potential source of stem cells in maternal lung.

S Pritchard, A M Hoffman, K L Johnson, D W Bianchi

Abstract readReview
In one paragraph

Review in Placenta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Novel insights into the link between fetal cell microchimerism and maternal cancers.Journal of cancer research and clinical oncology · 2016
    Review
  4. Review
  5. Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb.BioEssays : news and reviews in molecular, cellular and developmental biology · 2015
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of fetal-maternal microchimerism as a natural-born healer in integrity improvement of maternal damaged kidney.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S PritchardThe Mother Infant Research Institute at Tufts Medical Center, and Division of Genetics, The Floating Hospital for Children at Tufts Medical Center, 800 Washington Street, Boston, MA 02111, United States.
A M Hoffman
K L Johnson
D W Bianchi

Funding

The Role of Fetal Cell Microchimerism in Maternal RepairR01HD049469 · NICHD · TUFTS MEDICAL CENTER · PI BIANCHI, DIANA W. · 2005 to 2009
$1.6M
NICHD NIH HHS R01 HD04946-05NICHD NIH HHS R01 HD049469
6 · The paper itself

Abstract

Novel therapies are needed for the treatment of acute and chronic lung diseases, many of which are incurable. The use of exogenous stem cells has shown promise in both animal models and clinical trials. However, to date, the stem cell literature has under-recognized naturally acquired pregnancy-associated progenitor cells (PAPCs). These cells are found at sites of injury or disease in female tissues. They persist for decades after parturition in maternal blood and organs, with the largest number being found in the maternal lungs. Their presence there may be one explanation for the sex differences observed in the prevalence and prognosis of some lung diseases. Although the clinical significance of these cells is as yet unknown, the literature suggests that some of the PAPCs are stem cells or have stem cell-like properties. PAPCs harvested from the blood or organs of parous women could potentially be used as an alternate source of cells with regenerative properties for the woman herself or her children. Because PAPCs preferentially traffic to the maternal lung they may play a significant role in recovery or protection from lung disease. In this review article, we discuss ongoing research investigating the administration of both adult and placenta-derived stem cells to treat lung disease, and how PAPCs may also play an important future therapeutic role.

Indexed as

AnimalsDisease Models, AnimalEmbryonic Stem CellsFemaleHumansLung DiseasesMaleMicePlacentaPregnancyStem Cell Transplantation

Identifiers

PMID21546085
PMCPMC3157495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.